Mazor secured the first tranche of the investment of $7.5 million from a group of institutional and accredited investors, led by Oracle Investment Management founded by Larry Feinberg.
Under the structure of the transaction, the aggregate investment amount will be up to $15 million invested in two tranches of $7.5 million each and divided among a group of investors in varying percentages. The agreement provides up to $15 million for further investment capital and will facilitate the company’s efforts to implement an American Depository Receipt program on a U.S. stock exchange.
More Articles on Orthopedic Devices:
Stryker Names Kevin Lobo President, CEO
Arrowhead Medical Launches 2nd Generation Hammertoe Device
RTI Biologics Donates Allograft Tissue
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
